8,517 articles
Ron Waksman
Ron Waksman is an interventional cardiologist and researcher at MedStar Washington Hospital Center in Washington, DC, known for developing vascular brachytherapy to treat restenosis in stented arteries.
Ronald A. Arky
Ronald A. Arky is an American endocrinologist specializing in diabetes and metabolism who holds a distinguished professorship at Harvard Medical School and practices in Boston.
Ronald A. DePinho
Ronald A. DePinho is an American cancer biologist known for telomere and telomerase research who served as president of MD Anderson Cancer Center from 2011 to 2017.
Ronald A. Malt
Ronald A. Malt (1931–2002) was an American surgeon at Massachusetts General Hospital and Harvard professor who led the first successful reattachment of a completely severed human limb, in 1962.
Ronald A. Yankee
Ronald A. Yankee was a physician-scientist in hematology and transfusion medicine who pioneered selecting platelet donors by HL-A matching, showing matched platelets restore responses in refractory patients.
Ronald C. Kennedy
Ronald C. Kennedy, also known as Ronald Kennedy, was an American virus immunologist whose 1986 Science paper showed an anti-idiotypic antibody vaccine protected chimpanzees from hepatitis B.
Ronald C. Kessler
Ronald C. Kessler is an American psychiatric epidemiologist, McNeil Family Professor at Harvard Medical School, who led the US National Comorbidity Survey of mental disorders.
Ronald C. Petersen
Ronald C. Petersen is an American neurologist at Mayo Clinic in Rochester, Minnesota, best known for establishing mild cognitive impairment as a recognized diagnostic category.
Ronald de Wit
Ronald de Wit is a Dutch genitourinary medical oncologist and professor at Erasmus University Rotterdam, known for trials establishing docetaxel, cabazitaxel, and pembrolizumab in urologic cancers.
Ronald Dubner
Ronald Dubner (1934–2023) was an American pain researcher who led NIH's first pain research laboratory and later chaired pain sciences at the University of Maryland.
Ronald F. Dorfman
Ronald F. Dorfman was a South African-born American pathologist, an emeritus Stanford professor who helped establish hematopathology as a field, described Rosai-Dorfman disease, and died in 2012 aged 89.
Ronald Finn
Ronald Finn (1930–2004) was a British physician and researcher in Liverpool who, with Sir Cyril Clarke, developed anti-D prophylaxis, the "Liverpool shot" preventing Rhesus disease in newborns, sharing the 1980 Lasker Award.
Ronald G. Crystal
Ronald G. Crystal is an American physician-scientist in pulmonary medicine and gene therapy who developed the FDA-approved therapy for alpha-1 antitrypsin deficiency and pioneered human adenovirus gene transfer.
Ronald G. Haller
Ronald G. Haller is a neurologist and professor at UT Southwestern Medical Center in Dallas who directs a neuromuscular center and studies metabolic myopathies, including McArdle disease.
Ronald G. Strauss
Ronald G. Strauss was an American transfusion medicine physician and pediatric hematologist at the University of Iowa known for trials reshaping transfusion practice in premature infants.
Ronald G. Victor
Ronald G. Victor, also known as Ronald Victor, was an American cardiologist and hypertension researcher whose barbershop trials brought blood pressure in Black men under control.
Ronald H. Gray
Ronald H. Gray is an Australian-born reproductive epidemiologist, a professor at the Johns Hopkins Bloomberg School of Public Health known for HIV research in Rakai, Uganda.
Ronald J. Falk
Ronald J. Falk is an American nephrologist at the UNC School of Medicine whose 1988 identification of MPO-ANCAs reshaped diagnosis of small-vessel vasculitis; he chaired UNC's Department of Medicine until 2025.
Ronald J. Sokol
Ronald J. Sokol is an American pediatric gastroenterologist and hepatologist at the University of Colorado whose research established vitamin E deficiency as a treatable cause of neurologic disease.
Ronald J. Wapner
Ronald J. Wapner is an American maternal-fetal medicine specialist and reproductive geneticist who directs reproductive genetics at Columbia University, pioneered chorionic villus sampling, and led landmark prenatal diagnosis trials.
Ronald John Weigel
Ronald John Weigel is an American surgeon-scientist known for research on hormone response in breast cancer and elected to the National Academy of Medicine in 2018.
Ronald Klein
Ronald Klein was an American ophthalmologist and epidemiologist at the University of Wisconsin–Madison who led the Beaver Dam Eye Study and the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Ronald L. Nagel
Ronald L. Nagel (1936–2016) was a hematologist and geneticist at Albert Einstein College of Medicine in the Bronx who published over 300 papers on sickle cell disease and hemoglobin.
Ronald Levy (oncologist)
Ronald Levy, born in 1941, is an American medical oncologist and Stanford professor who pioneered monoclonal antibody therapy for lymphoma and helped develop rituximab, the first FDA-approved antibody cancer drug.
Ronald M. Bukowski
Ronald M. Bukowski is an American medical oncologist who specialized in genitourinary cancers at the Cleveland Clinic and co-led the TARGET trial, which established sorafenib for advanced kidney cancer.
Ronald M. Evans
Ronald M. Evans is an American molecular biologist at the Salk Institute known for discovering the nuclear hormone receptor superfamily, gene-regulating proteins targeted by many drugs.
Ronald M. Summers
Ronald M. Summers is an American radiologist and tenured Senior Investigator at the NIH Clinical Center in Bethesda, Maryland, where he directs the Imaging Biomarkers and Computer-Aided Diagnosis Laboratory.
Ronald P. DeMatteo
Ronald P. DeMatteo is an American surgical oncologist who chairs surgery at the University of Pennsylvania and led the ACOSOG Z9001 imatinib trial for GIST.
Ronald Ross
Sir Ronald Ross (1857-1932), British physician and Indian Medical Service officer, proved in 1897-1898 that mosquitoes transmit malaria, won the 1902 Nobel Prize in Physiology or Medicine, and founded mathematical epidemiology of mosquito-borne disease.
Ronald van Vollenhoven
Ronald F. van Vollenhoven (born 1960) is a Dutch rheumatologist, professor and chief of rheumatology at Amsterdam UMC since 2016, known for treat-to-target lupus recommendations and the 2025 telitacicept trial.